Empirico
PrivateLast Round
Series B
Mar 20, 2023
Total Funding Raised
$74.72M
Company Overview
Empirico is a biotechnology company that discovers and develops siRNA medicines designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Empirico Comparables
Compare Empirico with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deep Genomics | 86% | |
| Insitro | 82% | |
| ADARx Pharmaceuticals | 81% | |
Empirico Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 20, 2023 | ||||
| Series A Extension | Jan 9, 2020 | ||||
| Series A | Nov 1, 2018 |
Empirico Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series A Extension, Series A |
| New Enterprise Associates (NEA) | Series A |
| ARCH Venture Partners | Series A |
| Foresite Capital | Series A |
| Neotribe Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2018
$13M round led by ARCH Venture Partners, DCVC Bio, and Neotribe Ventures.
Empirico Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Empirico's valuation, stock price, and market status.